Reno Seth 4
4 · Gemphire Therapeutics Inc. · Filed Feb 12, 2018
Insider Transaction Report
Form 4
Reno Seth
Chief Commercial Officer
Transactions
- Purchase
Common Stock
2018-02-08$7.00/sh+14,286$100,002→ 18,286 total
Footnotes (1)
- [F1]The shares were purchased in a confidentially marketed public offering pursuant to an Underwriting Agreement. The offering closed on February 12, 2018.